Cefepime/zidebactam, sold under the brand name Zaynich, is a fixed-dose combination used for the treatment of complicated urinary tract infections. It contains cefepime, a cephalosporin antibacterial; and zidebactam, a beta-lactamase inhibitor and non-beta-lactam antibacterial.
It was approved for medical use in the United States in May 2026.
Medical uses Cefepime/zidebactam is indicated for the treatment of adults with complicated urinary tract infections including pyelonephritis caused by designated susceptible microorganisms.
Society and culture Legal status Cefepime/zidebactam was approved for medical use in the United States in May 2026.
Names Cefepime/zidebactam is sold under the brand name Zaynich.
References